Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GIKLY is expected to report earnings to rise 53.37% to 10 cents per share on July 24
Q2'25
Est.
$0.10
Q1'25
Missed
by $0.02
Q4'24
Beat
by $0.01
Q3'24
Missed
by $0.02
Q2'24
Est.
$0.04
The last earnings report on May 12 showed earnings per share of 6 cents, missing the estimate of 8 cents. With 902.00 shares outstanding, the current market capitalization sits at 8.78B.